Media release: HistologiX joins the BioHub at Alderley Park


ONE of the UK’s leading independent laboratories, providing quantitative Immunohistochemistry
(IHC) Immuno-Oncology and digital image analysis services, has taken tenancy at the BioHub, Alderley Park – increasing its foothold in the UK.

HistologiX Limited – which was formed in 2005 to provide quality Histology and
Immunohistochemistry (IHC) Services and multi-site clinical trial sample assessment for the pharmaceutical and biotechnology industry – has seen continuous development and growth at its headquarters at BioCity Nottingham.

Alderley Park provides outstanding bioscience facilities for R&D-focussed life science companies.

BioHub is a member of the BioCity Group and situated on the Manchester Science Parks site in Cheshire and is one of the leading science and technology park operators in Europe.

HistologiX joins the BioHub community from July 2019 as a tenant and will have an increased presence in the BioCity Group community with a new location for establishing new networks and connections.

Andrew Lawrence, of HistologiX, said: “BioHub is operated by the BioCity Group, so it feels like a natural step for us to have a presence at another BioCity location in addition to Nottingham.

“Being part of the BioCity community has provided our business with the ideal environment to grow and develop. With our new tenancy at BioHub we can expect some new North-Western connections that can also open the doors to new regional and national networks.”

The tenancy at BioHub is in line with HistologiX’ wider growth plans for the UK, while still delivering results which are robust, consistent, reproducible and accurate. This allows HistologiX to fully meet their client’s requirements and continually work in close collaboration with their clients to become in effect, an extension of their in-house teams.

Enquiries: HistologiX, Tel +44 (0) 115 912 4460

Notes for editors:

Tissue Solutions Ltd is a well-established global virtual biobank sourcing ethically-acquired, fully-consented human tissue and biomaterials to help scientists develop and test new drugs. The company provides a customised tissue provision service, quickly sourcing materials to individual requirements ensuring projects are not constrained by access to human biomaterials or collection timelines.

HistologiX Ltd is a leading, independent UK specialist histopathology company – which is GLP-accredited and GCP-compliant, providing precision quantitative IHC/ISH, histology services and solutions. HistologiX can assist with immunohistochemistry and in-situ hybridisation, tissue sourcing, medical/veterinary pathologist review, target development and distribution, efficacy studies, xenograft studies, tissue cross-reactivity of therapeutic antibodies and patient recruitment/stratification for clinical trials.

MEDIA RELEASE issued by Tissue Solutions. You too can share your stories (aka press or media releases), on this site. Email here for more information.

Check out for your very own media releases feed…

Check out too

Stay connected with our various twitter feeds: CharitiesDrinkEducationEnergyFashionFilmFoodGardensLegalMotorsMusicOutdoorsPropertyScience and Sports. And not forgetting FinanceTheatreTravelFestivalsVisual ArtsAberdeenDundeeEdinburghGlasgowInvernessPerth and Stirling.

Tissue Solutions contact details…

Contact: Fiona Mackenzie